John A Porco Selected Research

John A Porco Research Topics

Disease

27	Neoplasms (Cancer) 04/2024 - 07/2003
11	Lymphoma (Lymphomas) 01/2020 - 07/2003
3	Carcinogenesis 09/2014 - 07/2008
2	Neuroblastoma 04/2024 - 01/2021
2	Infections 02/2024 - 11/2015
2	Leukemia 01/2021 - 09/2014
2	B-Cell Lymphoma (Lymphoma, B Cell) 01/2020 - 04/2015
2	Hepatitis C 01/2019 - 10/2007
2	Dehydration (Water Stress) 03/2014 - 08/2005
2	Prostatic Neoplasms (Prostate Cancer) 12/2011 - 01/2009
1	Pancreatic Neoplasms (Pancreatic Cancer) 10/2022
1	Hepatocellular Carcinoma (Hepatoma) 01/2022
1	RNA Virus Infections 01/2022
1	Bacterial Infections (Bacterial Infection) 08/2021
1	Hypersensitivity (Allergy) 08/2021
1	Disease Progression 01/2020
1	Breast Neoplasms (Breast Cancer) 11/2019
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 11/2019
1	Hearing Loss (Hearing Impairment) 01/2019
1	Ototoxicity 01/2019
1	Alzheimer Disease (Alzheimer's Disease) 01/2019
1	Virus Diseases (Viral Diseases) 01/2019
1	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2019
1	Renal Cell Carcinoma (Grawitz Tumor) 11/2018
1	Multiple Myeloma 09/2014
1	Alopecia (Baldness) 11/2013
1	Neoplasm Metastasis (Metastasis) 12/2011
1	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 04/2010

Drug/Important Bio-Agent (IBA)

8	Proteins (Proteins, Gene)FDA Link 04/2024 - 02/2006
7	Transcription Factors (Transcription Factor)IBA 04/2024 - 07/2003
6	Peptide Initiation Factors (Initiation Factor)IBA 04/2024 - 07/2008
5	DNA (Deoxyribonucleic Acid)IBA 01/2019 - 07/2003
4	Eukaryotic Initiation Factor-4A (Eukaryotic Initiation Factor 4A)IBA 01/2022 - 01/2019
4	Eukaryotic Initiation Factor-4F (EIF4F)IBA 01/2021 - 04/2012
4	Eukaryotic Initiation Factor-4EIBA 01/2016 - 07/2008
4	silvestrolIBA 09/2014 - 07/2008
3	NF-kappa B (NF-kB)IBA 09/2006 - 07/2003
2	Small Interfering RNA (siRNA)IBA 01/2022 - 02/2006
2	Oncogene Proteins (Oncogene Protein)IBA 01/2020 - 09/2014
2	Dexamethasone (Maxidex)FDA LinkGeneric 01/2019 - 09/2014
2	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2019 - 01/2012
2	aglaroxin CIBA 01/2019 - 11/2015
2	Antineoplastic Agents (Antineoplastics)IBA 01/2016 - 12/2011
2	Cysteine (L-Cysteine)FDA Link 12/2011 - 02/2006
2	epoxyquinone AIBA 09/2006 - 02/2006
2	Caspase 3 (Caspase-3)IBA 02/2006 - 07/2003
1	5' Untranslated Regions (5' UTR)IBA 04/2024
1	PolyenesIBA 02/2024
1	EchinocandinsIBA 02/2024
1	AzolesIBA 02/2024
1	ClusterinIBA 10/2022
1	InterferonsIBA 01/2022
1	Antiviral Agents (Antivirals)IBA 01/2022
1	Immunologic Factors (Immunomodulators)IBA 08/2021
1	Eukaryotic Initiation FactorsIBA 01/2021
1	Aurora Kinase AIBA 01/2020
1	ProteomeIBA 01/2020
1	palbociclibIBA 11/2019
1	CyclinsIBA 11/2019
1	Cyclin D1IBA 11/2019
1	Estrogen ReceptorsIBA 11/2019
1	venetoclaxIBA 01/2019
1	Amino Acids FDA Link 01/2019
1	AminoglycosidesIBA 01/2019
1	Amyloid (Amyloid Fibrils)IBA 01/2019
1	EndonucleasesIBA 01/2019
1	EnzymesIBA 01/2019
1	Microtubule-Associated Proteins (Microtubule-Associated Protein 2)IBA 01/2019
1	Peptides (Polypeptides)IBA 01/2019
1	RNA (Ribonucleic Acid)IBA 01/2019
1	Messenger RNA (mRNA)IBA 01/2019
1	Oxidants (Oxidizing Agents)IBA 01/2019
1	rocaglamideIBA 11/2018
1	AcidsIBA 12/2015
1	SolventsIBA 12/2015
1	ProhibitinsIBA 11/2015
1	calafianinIBA 04/2015
1	streptococcal polysaccharide type III group BIBA 04/2015
1	Apoptosis Regulatory ProteinsIBA 04/2015
1	Sirtuin 1IBA 11/2014
1	Histone Deacetylases (Histone Deacetylase)IBA 11/2014
1	Histones (Histone)IBA 11/2014
1	TOR Serine-Threonine KinasesIBA 09/2014
1	RNA Helicases (RNA Helicase)IBA 09/2014
1	4-hydroxypyroneIBA 03/2014
1	SilverIBA 03/2014
1	3-hydroxybutanal (aldol)IBA 03/2014
1	sorbicillinolIBA 03/2014
1	sorbiterrin AIBA 03/2014
1	Cyclophosphamide (Cytoxan)FDA LinkGeneric 11/2013
1	parthenolideIBA 05/2012
1	CathepsinsIBA 12/2011
1	cyclohexenyl chalconeIBA 12/2011
1	proto-oncogene proteins pimIBA 08/2011
1	Phosphotransferases (Kinase)IBA 08/2011
1	Cytarabine (Cytosar-U)FDA LinkGeneric 04/2010
1	Etoposide (VP 16)FDA LinkGeneric 04/2010
1	Daunorubicin (Cerubidine)FDA LinkGeneric 04/2010

Therapy/Procedure

5	Drug Therapy (Chemotherapy) 01/2020 - 08/2011
2	Therapeutics 11/2014 - 08/2011